High Growth Tech Stocks in the UK for October 2024
In This Article:
Over the past 7 days, the United Kingdom market has experienced a drop of 1.4%, yet it has risen by 12% over the last year, with earnings forecasted to grow by 14% annually. In this context, identifying high growth tech stocks involves looking for companies that demonstrate strong potential for innovation and scalability in line with these positive market trends.
Top 10 High Growth Tech Companies In The United Kingdom
| Name | Revenue Growth | Earnings Growth | Growth Rating |
|---|---|---|---|
| Gaming Realms | 11.57% | 22.07% | ★★★★★☆ |
| STV Group | 13.15% | 46.78% | ★★★★★☆ |
| Altitude Group | 23.46% | 27.56% | ★★★★★☆ |
| Facilities by ADF | 52.00% | 144.70% | ★★★★★☆ |
| LungLife AI | 100.61% | 100.97% | ★★★★★☆ |
| Redcentric | 4.89% | 63.79% | ★★★★★☆ |
| Windar Photonics | 63.60% | 126.92% | ★★★★★☆ |
| Beeks Financial Cloud Group | 22.12% | 36.94% | ★★★★★☆ |
| Oxford Biomedica | 21.00% | 98.44% | ★★★★★☆ |
| Vinanz | 113.60% | 125.86% | ★★★★★☆ |
Click here to see the full list of 49 stocks from our UK High Growth Tech and AI Stocks screener.
Let's review some notable picks from our screened stocks.
Keywords Studios
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Keywords Studios plc offers creative and technical services to the global video game industry, with a market cap of ￡1.97 billion.
Operations: Keywords Studios generates revenue through three main segments: Create (€365.56 million), Engage (€180.43 million), and Globalize (€261.61 million).
Keywords Studios, amidst a transformative acquisition valued at ￡2 billion, is poised for significant financial shifts. With an expected revenue growth of 10.2% annually, surpassing the UK market average of 3.5%, and a forecast to transition from unprofitability to profitability within three years, the firm demonstrates robust potential in an evolving tech landscape. This growth trajectory is complemented by a substantial R&D investment focus, ensuring sustained innovation and competitiveness in high-tech sectors. The recent M&A activities not only underscore its strategic expansion but also enhance its service capabilities across global markets, promising a dynamic future for the company and its stakeholders.
-
Navigate through the intricacies of Keywords Studios with our comprehensive health report here.
-
Explore historical data to track Keywords Studios' performance over time in our Past section.
Oxford Biomedica
Simply Wall St Growth Rating: ★★★★★☆
Overview: Oxford Biomedica plc is a contract development and manufacturing organization dedicated to providing therapies globally, with a market capitalization of ￡448.83 million.
Operations: Oxford Biomedica generates revenue primarily from its Platform segment, amounting to ￡97.24 million. The company focuses on developing and manufacturing therapies for global distribution.